Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Ne... von Cooper, Jay S., MD, Zhang, Qiang, PhD, Pajak, Thomas F., PhD, Forastiere, Arlene A., MD, Jacobs, John, MD, Saxman, Scott B., MD, Kish, Julie A., MD, Kim, Harold E., MD, Cmelak, Anthony J., MD, Rotman, Marvin, MD, Lustig, Robert, MD, Ensley, John F., MD, Thorstad, Wade, MD, Schultz, Christopher J., MD, Yom, Sue S., MD, Ang, K. Kian, MD, PhD

Volltext

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck von Cooper, Jay S, Pajak, Thomas F, Forastiere, Arlene A, Jacobs, John, Campbell, Bruce H, Saxman, Scott B, Kish, Julie A, Kim, Harold E, Cmelak, Anthony J, Rotman, Marvin, Machtay, Mitchell, Ensley, John F, Chao, K.S. Clifford, Schultz, Christopher J, Lee, Nancy, Fu, Karen K

Volltext

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials von KORN, Edward L, LIU, Ping-Yu, PARULEKAR, Wendy, MARKOVIC, Svetomir N, SAXMAN, Scott, KIRKWOOD, John M, LEE, Sandra J, CHAPMAN, Judith-Anne W, NIEDZWIECKI, Donna, SUMAN, Vera J, MOON, James, SONDAK, Vernon K, ATKINS, Michael B, EISENHAUER, Elizabeth A

Volltext

Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial von Kim, Edward S, Prof, Neubauer, Marcus, MD, Cohn, Allen, MD, Schwartzberg, Lee, Prof, Garbo, Lawrence, MD, Caton, John, MD, Robert, Francisco, Prof, Reynolds, Craig, MD, Katz, Terry, MS, Chittoor, Sreeni, MD, Simms, Lorinda, PStat, Saxman, Scott, MD

Volltext

Population Variations in the Initial Treatment of Non–Small-Cell Lung Cancer von POTOSKY, Arnold L, SAXMAN, Scott, WALLACE, Robert B, LYNCH, Charles F

Volltext

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma von CHAPMAN, P. B, EINHORN, L. H, HOUGHTON, A. N, KIRKWOOD, J. M, MEYERS, M. L, SAXMAN, S, DESTRO, A. N, PANAGEAS, K. S, BEGG, C. B, AGARWALA, S. S, SCHUCHTER, L. M, ERNSTOFF, M. S

Volltext

Proposal for the Use of Progression-Free Survival in Unblinded Randomized Trials von FREIDLIN, Boris, KORN, Edward L, HUNSBERGER, Sally, GRAY, Robert, SAXMAN, Scott, ZUJEWSKI, Jo Anne

Volltext

Ethical Considerations for Outcome-adaptive Trial Designs: A Clinical Researcher's Perspective von Saxman, Scott Brian

Volltext

Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maint... von Zinner, Ralph G, Saxman, Scott B, Peng, Guangbin, Monberg, Matthew J, Ortuzar, Waldo I

Volltext

Commentary on Hey and Kimmelman von Saxman, Scott Brian

Volltext

Prospective Study of Fluorodeoxyglucose–Positron Emission Tomography Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node Biopsy von WAGNER, J. D, SCHAUWECKER, D, DAVIDSON, D, COLEMON, J. J, SAXMAN, S, HUTCHINS, G, LOVE, C, HAYES, J. T

Volltext

Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group von Gray, Robert, Manola, Judith, Saxman, Scott, Wright, John, Dutcher, Jan, Atkins, Michael, Carducci, Michael, See, William, Sweeney, Christopher, Liu, Glenn, Stein, Mark, Dreicer, Robert, Wilding, George, DiPaola, Robert S

Volltext

National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation von Bleyer, Archie, Montello, Michael, Budd, Troy, Saxman, Scott

Volltext

Pulmonary Toxicity in Patients With Advanced-Stage Germ Cell Tumors Receiving Bleomycin With and Without Granulocyte Colony Stimulating Factor von Saxman, Scott B., Nichols, Craig R., Einhorn, Lawrence H.

Volltext

Doctor … Will I Still Be Able To Have Children? von Saxman, Scott

Volltext

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carc... von SAXMAN, S. B, PROPERT, K. J, EINHORN, L. H, CRAWFORD, E. D, TANNOCK, I, RAGHAVAN, D, LOEHRER, P. J, SR, TRUMP, D

Volltext

Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial von Lu, Charles, Lee, J. Jack, Komaki, Ritsuko, Herbst, Roy S., Feng, Lei, Evans, William K., Choy, Hak, Desjardins, Pierre, Esparaz, Benjamin T., Truong, Mylene T., Saxman, Scott, Kelaghan, Joseph, Bleyer, Archie, Fisch, Michael J.

Volltext

Soft tissue sarcomas of adults: State of the translational science von BORDEN, Ernest C, BAKER, Lurence H, O'SULLIVAN, Brian, PARKINSON, David R, PISTERS, Peter W. T, SAXMAN, Scott, SINGER, Samuel, SUNDARAM, Murali, VAN OOSTEROM, Allan T, VERWEIJ, Jaap, WAALEN, Jill, WEISS, Sharon W, BELL, Robert S, BRENNAN, Murray F, BRAMWELL, Vivien, DEMETRI, George D, EISENBERG, Burton L, FLETCHER, Christopher D. M, FLETCHER, Jonathan A, LADANYI, Marc, MELTZER, Paul

Volltext

Molecular marker assessments for epidermal growth factor receptor (EGFR) expression by immunohistochemistry (IHC) and histoscore (H-score) in the phase III SELECT trial von Kim, Edward S., Chittoor, Sreenivas, Reynolds, Craig H., Simms, Lorinda, Saxman, Scott

Volltext

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America meaningful improvements in survival von JÄNNE, Pasi A, FREIDLIN, Boris, SAXMAN, Scott, JOHNSON, David H, LIVINGSTON, Robert B, SHEPHERD, Frances A, JOHNSON, Bruce E

Volltext